Skip to main content
. Author manuscript; available in PMC: 2024 Mar 3.
Published in final edited form as: Annu Rev Nutr. 2023 May 19;43:25–54. doi: 10.1146/annurev-nutr-062220-112240

Table 2.

FABP dysregulation in cancer

Cancer type FABP(s) Association Reference
Intestine FABP1 FABP1 deletion protects against tumorigenesis in a small intestinal adenoma mouse model 32
Enhanced FABP1 expression in small intestine epithelial cells promotes tumorigenesis 1
FABP4 High expression has been shown in colon cancer tissue 173
FABP5 FABP5 upregulation promotes proliferation in colon cancer cells 153
FABP7 High expression correlates with cell proliferation in colon cancer tissues 117
Gastrointestinal stromal cancer FABP3 High FABP3 protein expression 22
Gastric FABP5 FABP5 knockdown decreases proliferation 201
Esophageal FABP3 High FABP3 protein expression 29
Liver FABP1 High FABP1 protein expression in hepatocellular carcinoma tissues 93
FABP4 High expression in liver cancer stem cells 193
High expression in hepatic stellate cells in hepatocellular carcinoma 26
Non-small cell lung cancer FABP3 High FABP3 mRNA and protein expression in NSCLC tumor tissues 171
FABP5 Knockdown decreases proliferation of lung adenocarcinoma cells 52
FABP7 FABP7 is prometastatic in NSCLC cell lines 9
Breast FABP2 Transcriptional modulation by hormones and microenvironment in culture cells 113
FABP3 Transcriptional modulation by hormones and microenvironment in culture cells 113
High protein expression in tumor tissues and adipose microenvironment 110
FABP4 High protein expression in tumor tissues and adipose microenvironment 110
FABP5 High protein expression in tumor tissues and adipose microenvironment 110
FABP7 High expression of FABP7 in human triple-negative breast cancer tissue 108
Uterine sarcoma FABP3 High FABP3 expression in tumor tissues 30
Ovary FABP4 High expression in ovarian cancer tissues 56
Melanoma FABP8 High FABP8 protein expression 59
FABP7 FABP7 knockdown decreased proliferation in melanoma cell lines 176
Squamous cell carcinoma FABP7 FABP7 levels reduced in patient samples 168
Renal FABP5 FABP5 silencing inhibited proliferation of renal clear cell carcinoma cells 114
Prostate cancer FABP5 Knockdown of FABP5 decreases proliferation in vitro 132
FABP9 High FABP9 protein expression in cultured cells 3
FABP12 FABP12 in metastatic prostate cancer 106
Bladder FABP6 FABP6 knockdown decreases cell cycle progression and migration in vitro 105
Glioma FABP4 High expression in glioblastoma tissue and cell lines 111
FABP5 Suppression of FABP5 decreases proliferation in vitro 180
FABP6 Knockdown of FABP6 in glioblastoma cells reduced tumor cell invasion 137
FABP7 Overexpression of FABP7 increases proliferation of glioblastoma cells 81
Overexpression of FABP7 protective in glioma cell line 74
Neuroblastoma FABP4 High expression in tumor-associated macrophages in neuroblastoma 123
Leukemia FABP4 High expression in acute myeloid leukemia cells 195
Lymphoma FABP7 Ectopic expression in patients with large B cell lymphoma 112

Abbreviations: FABP, fatty acid–binding protein; NSCLC, non-small cell lung cancer.